| Schedule of accrued expenses |
| | | | | | | | | June 30, 2026 | | September 30, 2025 | Compensation | | $ | 812,537 | | $ | 1,437,049 | Severance and related costs | | | 243,144 | (i) | | 1,590,835 | Professional fees | | | 184,381 | | | 195,623 | Research and development | | | 159,462 | | | 1,188,212 | Accrued rebates | | | 1,659,057 | | | 317,754 | Other accrued expenses | | | 220,158 | | | 584,847 | | | $ | 3,278,739 | | $ | 5,314,320 |
| (i) | In September 2025, the Company implemented workforce reductions to conserve capital. Both the Company’s Chief Executive Officer and Chief Commercial Officer departed from the Company during the fiscal year ended September 30, 2025, and their departures each constituted terminations without cause. Accordingly, each was entitled to 12 months of base salary, a lump sum of 100% of their target bonus for the year, employee benefits for up to 12 months, full vesting of 50% of their unvested equity awards, and reimbursement of expenses owed up to their termination dates. At a minimum, all employees affected by the workforce reduction were eligible to receive severance payments and paid COBRA premiums for a specified time period post-termination, subject to execution of a general release of claims against the Company. |
|